RT Book, Section
A1 Bashore, Thomas M.
A1 Granger, Christopher B.
A1 Jackson, Kevin P.
A1 Patel, Manesh R.
A2 Papadakis, Maxine A.
A2 McPhee, Stephen J.
A2 Rabow, Michael W.
A2 McQuaid, Kenneth R.
SR Print(0)
ID 1184694964
T1 Adult Congenital Heart Disease
T2 Current Medical Diagnosis & Treatment 2022
YR 2022
FD 2022
PB McGraw-Hill Education
PP New York, NY
SN 9781264269389
LK accessmedicine.mhmedical.com/content.aspx?aid=1184694964
RD 2024/04/24
AB Congenital  lesions  account  for  only  about  2%  of  heart  disease  that  presents  in  adulthood.  As  surgical  and  medical  techniques  have  improved,  more  and  more  children  are  now  reaching  adulthood.  In  the  United  States,  there  are  many  more  adults  with  congenital  heart  disease  than  children,  with  an  estimated  2  million  adults  in  the  United  States  surviving  with  congenital  heart  disease.  In  2018,  the  American  College  of  Cardiology  (ACC)  and  American  Heart  Association  (AHA)  released  updated  guidelines  for  the  assessment  and  treatment  of  patients  with  adult  congenital  heart  disease.  The  European  Society  of  Cardiology  (ESC)  completed  their  update  on  the  same  topic  in  2020.  As  the  number  of  patients  with  adult  congenital  heart  disease  has  grown,  there  has  been  an  increased  appreciation  of  the  need  for  more  training  and  guidelines.  A  specific  subspecialty  board  and  training  program  has  been  established.  The  AHA  also  issued  a  scientific  statement  in  2015  reviewing  common  issues  for  adults  with  underlying  congenital  heart  disease,  another  statement  in  2017  for  pregnant  patients  with  congenital  heart  disease,  and  a  statement  in  2017  regarding  noncardiac  issues  in  these  patients.